{
  "id": "2af8a00478a43e33",
  "title": "JPM 2026 : FDA panelists prioritize faster approvals , national security , AI , and more | Hogan Lovells",
  "description": "20260122T004500Z",
  "content": "",
  "source": "jdsupra.com",
  "source_url": "https://www.jdsupra.com/legalnews/jpm-2026-fda-panelists-prioritize-5939530/",
  "published_at": "20260122T004500Z",
  "fetched_at": "2026-01-23T00:24:24.269073+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai",
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.jdsupra.com/legalnews/jpm-2026-fda-panelists-prioritize-5939530/",
    "url_mobile": "",
    "title": "JPM 2026 : FDA panelists prioritize faster approvals , national security , AI , and more | Hogan Lovells",
    "seendate": "20260122T004500Z",
    "socialimage": "https://jdsupra-static.s3.amazonaws.com/profile-images/og.15723_2410.jpg",
    "domain": "jdsupra.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}